A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdh107 ◽

2004 ◽

Vol 15 (3) ◽

pp. 433-439 ◽

Cited By ~ 28

Author(s):

S. Cresta ◽

G. Grasselli ◽

M. Mansutti ◽

A. Martoni ◽

G. Lelli ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Randomized phase II study ofnab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

Cancer Science ◽

10.1111/cas.13221 ◽

2017 ◽

Vol 108 (5) ◽

pp. 987-994 ◽

Cited By ~ 7

Author(s):

Kenji Tamura ◽

Kenichi Inoue ◽

Norikazu Masuda ◽

Shintaro Takao ◽

Masahiro Kashiwaba ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Three-arm randomized phase II study evaluating oral vinorelbine plus capecitabine versus paclitaxel plus gemcitabine versus docetaxel plus gemcitabine as first-line chemotherapy in patients with metastatic breast cancer: Final results (NorCap-CA223 trial).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1044 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1044-1044 ◽

Cited By ~ 1

Author(s):

Saverio Cinieri ◽

Arlene Chan ◽

Kadri Altundag ◽

Ann Vandebroek ◽

Nicole Tubiana-Mathieu ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Randomized Phase Ii ◽

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Annals of Oncology ◽

10.1093/annonc/mdx772 ◽

2018 ◽

Vol 29 (3) ◽

pp. 661-668 ◽

Cited By ~ 1

Author(s):

A. Gennari ◽

Z. Sun ◽

U. Hasler-Strub ◽

M. Colleoni ◽

M.J. Kennedy ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

Maintenance Schedules ◽

First Line Treatment

2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70892-3 ◽

2007 ◽

Vol 5 (4) ◽

pp. 223

Author(s):

N. Tubiana-Mathieu ◽

P. Bougnoux ◽

D. Becquart ◽

A. Chan ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

BMC Cancer ◽

10.1186/1471-2407-6-76 ◽

2006 ◽

Vol 6 (1) ◽

Cited By ~ 8

Author(s):

Alessandro Passardi ◽

Ilaria Massa ◽

Wainer Zoli ◽

Lorenzo Gianni ◽

Carlo Milandri ◽

...

Keyword(s):

Breast Cancer ◽

Translational Research ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Research Experience ◽

First Line ◽

Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC). Final results of a Phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(02)80203-9 ◽

2002 ◽

Vol 38 (11) ◽

pp. S68 ◽

Cited By ~ 1

Author(s):

S Morales

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Phase II study of vinorelbine (alternating intravenous and oral) in combination with docetaxel as first-line chemotherapy in metastatic breast cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-008-0816-5 ◽

2008 ◽

Vol 63 (5) ◽

pp. 937-943 ◽

Cited By ~ 6

Author(s):

Mario Campone ◽

Maria Blasinska-Morawiec ◽

Anna Tekiela ◽

Piotr Koralewski ◽

Jean-Christophe Pouget ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1558-3 ◽

2011 ◽

Vol 128 (2) ◽

pp. 437-445 ◽

Cited By ~ 5

Author(s):

R. I. Lalisang ◽

F. L. G. Erdkamp ◽

C. J. Rodenburg ◽

C. T. A. M. Knibbeler-van Rossum ◽

J. W. R. Nortier ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Dose Dense